Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Makowska Rasmussen, C. Porsbjerg, A. Høegholm, V. Backer (Næstved, Hillerød, Copenhagen, Denmark). Can smoking asthmatic subjects benefit from anti-asthmatic treatment?. Eur Respir J 2007; 30: Suppl. 51, 268

Member's Comments

No comment yet.

Related content which might interest you: The influence of smoking on the treatment response in patients with asthma Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 Comparative effectiveness of add-on omalizumab for the treatment of severe persistent asthma between current and former smokers vs. non-smokers Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018 How often do asthma patients claim prescribed therapy? Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017 Rescue/acute and allergy medication use among children on asthma controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004 Are severe asthmatics still smoking? Source: International Congress 2017 – Smoking and health hazards Year: 2017 Pharmacogenetics of anti-inflammatory treatment in children with asthma Source: Annual Congress 2013 –Towards personalised medicine in respiratory diseases in children Year: 2013 Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Is omalizumab response influenced by passive smoking in severe asthma? Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Changes in the use of anti-asthmatic medication in an international cohort Source: Eur Respir J 2005; 26: 1047-1055 Year: 2005 Features of anti-inflammatory therapy of bronchial asthma in children with overweight andobesity Source: Virtual Congress 2020 – Paediatric asthma Year: 2020 Treating smoking asthmatics Source: International Congress 2015 – Asthma and smoking: dangerous liaisons - an interactive session Year: 2015 Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Potential drugs to treat smokers with asthma Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 The cost-effectiveness of antidepressants for smoking cessation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006 Do symptomatic asthmatic smokers need a higher maintenance dose when treated with budesonide/formoterol maintenance and reliever therapy than non-smokers? Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 The value of behavioral regulation in patients with bronchial asthma in case of smoking cessation Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation Year: 2019 Passive smoking and the airways reaction to inhaled corticosteroid therapy in children with asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma Year: 2007